Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
2022 healthcare megatrends shaping the surgical-device sector This infographic looks at three trends in healthcare that… General surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Surgical device | Asia | Europe | Middle East & Africa | Cardiovascular Surgery | Minimally invasive surgery | Orthopaedic & Spine Surgery | Robotic surgery | Surgical Gateway | Urology
Rapid antigen tests to erode PCR-based molecular covid test market in APAC Emergent covid-19 screening technologies coupled with… Covid-19 testing | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Molecular diagnostics instrument sales in Asia-Pacific set to normalise as vaccination rates rise Molecular diagnostics (MDX) instrument sales in Asia-Pacific… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Covid-19: Molecular testing capacity expands in Asia-Pacific Molecular diagnostics (MDx) testing capacities and… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway | Molecular Diagnostics (MDx)
Trends in minimally invasive cardiovascular surgery in Japan In this infographic, we look at three MIS procedure areas… Cardiovascular surgery | Minimally invasive surgery | Surgical device | Asia | Cardiovascular Surgery | Minimally invasive surgery | Surgical Gateway
2025: five trends in South-east Asia’s cardiovascular surgery and device market Our latest infographic explores the five trends in… Uncategorised | Asia
Covid-19: accelerating digitalisation of surgical platforms and solutions The covid-19 pandemic has accelerated the rise of telehealth… Covid-19 testing | General surgery | Global | Surgical Gateway
Asia surgery boom a key source of opportunities for global medtech companies Surgical procedure volume and the device market is expected… Surgical device | Asia | Surgical Gateway
Tissue-based companion diagnostics market to grow for the most common cancers in China Companion diagnostics (CDx) use is growing as the cancer… In-vitro diagnostics | Tissue Diagnostics (TDx) | Asia | IVD Gateway | Tissue Diagnostics (TDx)
Competition in the APAC IVD infectious diseases diagnostics market Competition in Asia-Pacific’s infectious diseases… In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | IVD Gateway
Point-of-care vs. lab-based covid-19 testing Covid-19 testing has emerged as a top priority for clinical… In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Infectious disease IVD testing: Where APAC countries are putting their attention Economist Intelligence Clearstate expects strong growth for… In-vitro diagnostics | Asia | IVD Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now